Living Rheum
Dedicated to uncovering clinical developments and treatment advancements in the field of rheumatology, Living Rheum delivers expert insights on patient management across a broad spectrum of rheumatic diseases, such as rheumatoid arthritis, lupus, scleroderma, osteoporosis, and more.
1-15 of 100
Depression in Sjögren’s Disease Extends Beyond Physical Symptom Burden
Living RheumDepression in Sjögren’s Disease Extends Beyond Physical Symptom Burden
Cardiovascular Risk in Women with Sjögren's Disease
Living RheumCardiovascular Risk in Women with Sjögren's Disease
A Look at Ocular Manifestations of Sjögren’s Disease
Living RheumA Look at Ocular Manifestations of Sjögren’s Disease
Esen Akpek, MD
Diagnostic Testing and Treatment of Dry Eye in Sjögren’s Disease
Living RheumDiagnostic Testing and Treatment of Dry Eye in Sjögren’s Disease
Esen Akpek, MD
Sjögren’s-Related Dry Eye: Lifestyle and Supportive Measures
Living RheumSjögren’s-Related Dry Eye: Lifestyle and Supportive Measures
Esen Akpek, MD
Unmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Living RheumUnmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Steve Jackson, PharmD
Maria Dall'Era, MD
- advertisement
Improving Psoriatic Arthritis Care Through Patient-Centered Research
Living RheumImproving Psoriatic Arthritis Care Through Patient-Centered Research
Alexis Ogdie-Beatty, MD, MSCE
Identifying and Diagnosing RA-Associated Interstitial Lung Disease
Living RheumIdentifying and Diagnosing RA-Associated Interstitial Lung Disease
Bryant England, MD, PhD
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Living RheumChoosing a JAK Inhibitor for Rheumatoid Arthritis
Roy Fleischmann, MD, MACR
Shared Decision-Making in Rheumatoid Arthritis Care
Living RheumShared Decision-Making in Rheumatoid Arthritis Care
Elena Myasoedova, MD, PhD
Beyond the Black Box: JAK Inhibitor Safety in RA
Living RheumBeyond the Black Box: JAK Inhibitor Safety in RA
Roy Fleischmann, MD, MACR
Nancy Carteron, MD
- advertisement
The Spectrum of Neurologic Conditions in Sjögren's Patients
Living RheumThe Spectrum of Neurologic Conditions in Sjögren's Patients
Nancy Carteron, MD
What's Next for Sjögren's Disease Treatment?
Living RheumWhat's Next for Sjögren's Disease Treatment?
Nancy Carteron, MD
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
Living RheumIFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease